
pmid: 39394465
handle: 11573/1723554 , 11568/1285474 , 11571/1508992
AbstractJoubert syndrome (JS) is a genetically heterogeneous neurodevelopmental ciliopathy. Despite exome sequencing (ES), several patients remain undiagnosed. This study aims to increase the diagnostic yield by uncovering cryptic variants through targeted ES reanalysis. We first focused on 26 patients in whom ES only disclosed heterozygous pathogenic coding variants in a JS gene. We reanalyzed raw ES data searching for copy number variants (CNVs) and intronic variants affecting splicing. We validated CNVs through real-time PCR or chromosomal microarray, and splicing variants through RT-PCR or minigenes. Cryptic variants were then searched in additional 44 ES-negative JS individuals. We identified cryptic “second hits” in 14 of 26 children (54%) and biallelic cryptic variants in 3 of 44 (7%), reaching a definite diagnosis in 17 of 70 (overall diagnostic gain 24%). We show that CNVs and intronic splicing variants are a common mutational mechanism in JS; more importantly, we demonstrate that a significant proportion of such variants can be disclosed simply through a focused reanalysis of available ES data, with a significantly increase of the diagnostic yield especially among patients previously found to carry heterozygous coding variants in the KIAA0586, CC2D2A and CPLANE1 genes.
Male, Heterozygote, Adolescent, DNA Copy Number Variations, RNA Splicing, 610, Cell Cycle Proteins, Cerebellum / abnormalities, Abnormalities, Multiple / genetics, Article, Cytoplasmic Dyneins / genetics, Exome Sequencing, Kidney Diseases, Cystic / diagnosis, Humans, Child, Retina / abnormalities, Infant, Kidney Diseases, Cystic / genetics, Membrane Proteins, Eye Abnormalities / genetics, Retina / pathology, Abnormalities, Multiple / diagnosis, Cytoskeletal Proteins, Cytoskeletal Proteins [MeSH] ; Heterozygote [MeSH] ; Kidney Diseases, Cystic/genetics [MeSH] ; Abnormalities, Multiple/genetics [MeSH] ; Cytoplasmic Dyneins/genetics [MeSH] ; Cerebellum/abnormalities [MeSH] ; /631/208/2489/144 ; Cell Cycle Proteins [MeSH] ; RNA Splicing [MeSH] ; Infant [MeSH] ; Male [MeSH] ; Retina/abnormalities [MeSH] ; Eye Abnormalities/genetics [MeSH] ; Exome/genetics [MeSH] ; Retina/pathology [MeSH] ; Child [MeSH] ; Abnormalities, Multiple/diagnosis [MeSH] ; Cerebellum/pathology [MeSH] ; Adolescent [MeSH] ; Female [MeSH] ; Mutation [MeSH] ; /692/308/2056 ; Humans [MeSH] ; Membrane Proteins [MeSH] ; Exome Sequencing [MeSH] ; DNA Copy Number Variations [MeSH] ; Article ; Eye Abnormalities/diagnosis [MeSH] ; Kidney Diseases, Cystic/diagnosis [MeSH] ; article ; Child, Preschool [MeSH], Eye Abnormalities / diagnosis, Cerebellum / pathology, Exome / genetics, Child, Preschool, Mutation, Humans; Kidney Diseases, Cystic/genetics; Kidney Diseases, Cystic/diagnosis; Abnormalities, Multiple/genetics; Abnormalities, Multiple/diagnosis; Cerebellum/abnormalities; Cerebellum/pathology; Eye Abnormalities/genetics; Eye Abnormalities/diagnosis; DNA Copy Number Variations; Retina/abnormalities; Retina/pathology; Female; Male; Child; Exome Sequencing; RNA Splicing; Child, Preschool; Mutation; Adolescent; Heterozygote; Infant; Exome/genetics; Cytoplasmic Dyneins/genetics; Cytoskeletal Proteins; Membrane Proteins; Cell Cycle Proteins, Female, Joubert syndrome; Pathogenic cryptic variants; exome data reanalysis;
Male, Heterozygote, Adolescent, DNA Copy Number Variations, RNA Splicing, 610, Cell Cycle Proteins, Cerebellum / abnormalities, Abnormalities, Multiple / genetics, Article, Cytoplasmic Dyneins / genetics, Exome Sequencing, Kidney Diseases, Cystic / diagnosis, Humans, Child, Retina / abnormalities, Infant, Kidney Diseases, Cystic / genetics, Membrane Proteins, Eye Abnormalities / genetics, Retina / pathology, Abnormalities, Multiple / diagnosis, Cytoskeletal Proteins, Cytoskeletal Proteins [MeSH] ; Heterozygote [MeSH] ; Kidney Diseases, Cystic/genetics [MeSH] ; Abnormalities, Multiple/genetics [MeSH] ; Cytoplasmic Dyneins/genetics [MeSH] ; Cerebellum/abnormalities [MeSH] ; /631/208/2489/144 ; Cell Cycle Proteins [MeSH] ; RNA Splicing [MeSH] ; Infant [MeSH] ; Male [MeSH] ; Retina/abnormalities [MeSH] ; Eye Abnormalities/genetics [MeSH] ; Exome/genetics [MeSH] ; Retina/pathology [MeSH] ; Child [MeSH] ; Abnormalities, Multiple/diagnosis [MeSH] ; Cerebellum/pathology [MeSH] ; Adolescent [MeSH] ; Female [MeSH] ; Mutation [MeSH] ; /692/308/2056 ; Humans [MeSH] ; Membrane Proteins [MeSH] ; Exome Sequencing [MeSH] ; DNA Copy Number Variations [MeSH] ; Article ; Eye Abnormalities/diagnosis [MeSH] ; Kidney Diseases, Cystic/diagnosis [MeSH] ; article ; Child, Preschool [MeSH], Eye Abnormalities / diagnosis, Cerebellum / pathology, Exome / genetics, Child, Preschool, Mutation, Humans; Kidney Diseases, Cystic/genetics; Kidney Diseases, Cystic/diagnosis; Abnormalities, Multiple/genetics; Abnormalities, Multiple/diagnosis; Cerebellum/abnormalities; Cerebellum/pathology; Eye Abnormalities/genetics; Eye Abnormalities/diagnosis; DNA Copy Number Variations; Retina/abnormalities; Retina/pathology; Female; Male; Child; Exome Sequencing; RNA Splicing; Child, Preschool; Mutation; Adolescent; Heterozygote; Infant; Exome/genetics; Cytoplasmic Dyneins/genetics; Cytoskeletal Proteins; Membrane Proteins; Cell Cycle Proteins, Female, Joubert syndrome; Pathogenic cryptic variants; exome data reanalysis;
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 6 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
